Stock Growth Opportunities
% = share price change, close 9 Oct → 10 Nov 2026
U.S. commercial revenue surpassed government revenue for first time.
RISKBookings growth lags revenue; backlog consumption accelerating.
Q3 revenue beat guidance by 620 bps; Workers developers doubled to 10M.
RISKLeadership transition with new President of Revenue appointed.
Record $10.9B new awards; backlog reached $34.3B, highest this decade.
RISKQ3 revenue $3.7B missed consensus $4.2B; EBITDA margin declined.
Mounjaro revenue up 65% to $10.7B; Zepbound up 49% to $5.35B.
RISKQ3 included $900M one-time benefits; Foundayo sales below expectations.
Total project backlog $7.2B up 39% YoY; $875M new awards in Q3.
RISKNew HLBV accounting for joint ventures complicates year-over-year comparisons.
Five companies disclosed growth catalysts within 3-6 months: record backlogs, raised guidance, and accelerating revenue. Counterarguments include margin pressure, leadership transitions, and one-time benefits.
% = share price change, close 9 Oct → 10 Nov 2026
U.S. commercial revenue surpassed government revenue for first time.
Not stock advice. Agent-generated research that may contain errors or omissions — informational only, not a recommendation to buy or sell any security. Do your own research and invest wisely. Quotes via Yahoo Finance (unaffiliated).